BioSpace News Archive

Business

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019, Provides Financial Outlook for 2020

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced preliminary financial results for the fourth quarter and full year 2019 and provided 2020 financial guidance.

January 13, 2020
·
3 min read
Drug Development

Revolution Medicines Presents Data from its SHP2 and Oncogenic RAS(ON) Programs at 6th AACR-IASLC International Joint Conference

Revolution Medicines, Inc., today announced that preliminary data from the company’s Phase 1 clinical trial (RMC-4630-01) of RMC-4630 were reported in podium and poster presentations at the 6th AACR-IASLC International Joint Conference: Lung Cancer Translational Science

January 13, 2020
·
3 min read
Pharm Country

PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference

PTC Therapeutics, Inc. (NASDAQ: PTCT) today is providing a corporate update that will be presented at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15th at 8:30 a.m. PST

January 13, 2020
·
12 min read
Business

OneOncology Expands to New England with Eastern Connecticut Hematology and Oncology

OneOncology, the national network of independent community oncologists, announced its new partnership with Eastern Connecticut Hematology and Oncology as the company expands its footprint across New England.

January 13, 2020
·
2 min read
BioCapital

Charles River Laboratories to Present at the 38th Annual J.P. Morgan Healthcare Conference

Charles River Laboratories International, Inc. announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, January 14th, at 9:30 a.m. PST, followed by a question and answer session at 10:00 a.m. PST.

January 13, 2020
·
1 min read
Biotech Bay

Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule

Titan Pharmaceuticals, Inc. announced that it has signed an agreement for Probuphine implant to be included on the Federal Supply Schedule, providing U.S. veterans and other federal government agencies with access to Titan’s novel 6-month maintenance treatment for Opioid Use Disorder in eligible patients.

January 13, 2020
·
9 min read
Drug Development

Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to Treat NTM Infections

Crestone, Inc. today announced an award from the Cystic Fibrosis Foundation (CFF) for the preclinical development of its antibiotic lead series to treat nontuberculous mycobacteria (NTM) infections, focusing on M. abscessus.

January 13, 2020
·
2 min read
Business

Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results

Accelerate Diagnostics, Inc., announced preliminary financial results for the quarter and year ending December 31, 2019.

January 13, 2020
·
4 min read
Drug Development

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

Primary endpoint met at all doses: ensifentrine produced clinically and statistically significant dose-dependent improvements in lung function

January 13, 2020
·
10 min read
Pharm Country

Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications

Adaptimmune Therapeutics plc reported at the 38th JP Morgan Healthcare Conference, two confirmed Partial Responses – one in a patient with liver cancer and one in a patient with melanoma.

January 13, 2020
·
4 min read